Related Experiment Videos
Advances in the macrolides and quinolones
1Department of Medical Microbiology, City Hospital NHS Trust, Birmingham, United Kingdom.
Infectious Disease Clinics of North America
|October 21, 1998
Summary
Widespread antibiotic resistance necessitates new drugs and smarter use of current ones. Research focuses on novel compounds with better efficacy and safety profiles to combat resistant bacterial infections.
Area of Science:
- Microbiology
- Pharmacology
- Infectious Diseases
Background:
- Extensive clinical application of macrolides and quinolones has driven resistance in multiple bacterial species.
- Rising antimicrobial resistance poses a significant threat to public health and effective treatment of infections.
Purpose of the Study:
- To highlight the urgent need for novel antimicrobial agents.
- To emphasize the requirement for improved drug properties, including broader spectra, enhanced pharmacokinetics, and minimized adverse effects.
- To advocate for the judicious and strategic utilization of existing antibiotic therapies.
Main Methods:
- Literature review on antibiotic resistance trends.
- Analysis of current antimicrobial drug development pipelines.
- Evaluation of pharmacokinetic and pharmacodynamic principles for novel agents.
Main Results:
- Significant resistance has emerged to commonly used macrolides and quinolones.
- Development of new antimicrobial compounds is crucial to overcome existing resistance mechanisms.
- Optimizing the use of current antibiotics is essential alongside new drug discovery.
Conclusions:
- Novel antimicrobial agents with superior characteristics are imperative to address escalating resistance.
- A dual approach combining the development of new drugs and the rational use of existing ones is necessary for effective antimicrobial stewardship.